Literature DB >> 22864683

Expression of VAV1 in the tumour microenvironment of glioblastoma multiforme.

Juan Luis Garcia1, Jose Couceiro, Juan Antonio Gomez-Moreta, J M Gonzalez Valero, Angel Santos Briz, Vincent Sauzeau, Eva Lumbreras, Manuel Delgado, Cristina Robledo, Monica Lara Almunia, Xose R Bustelo, Jesus M Hernandez.   

Abstract

Even though much progress has been made towards understanding the molecular nature of glioma, the survival rates of patients affected by this tumour have not changed significantly over recent years. Better knowledge of this malignancy is still needed in order to predict its outcome and improve patient treatment. VAV1 is an GDP/GTP exchange factor for Rho/Rac proteins with oncogenic potential that is involved in the regulation of cytoskeletal dynamics and cell migration. Here we report its overexpression in 59 patients diagnosed with high-grade glioma, and the associated upregulation of a number of genes coding for proteins also involved in cell invasion- and migration-related processes. Unexpectedly, immunohistochemical experiments revealed that VAV1 is not expressed in glioma cells. Instead, VAV1 is found in non-tumoural astrocyte-like cells that are located either peritumouraly or perivascularly. We propose that the expression of VAV1 is linked to synergistic signalling cross-talk between cancer and infiltrating cells. Interestingly, we show that the pattern of expression of VAV1 could have a role in the neoplastic process in glioblastoma tumours.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864683     DOI: 10.1007/s11060-012-0936-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Gene expression profiling of gliomas strongly predicts survival.

Authors:  William A Freije; F Edmundo Castro-Vargas; Zixing Fang; Steve Horvath; Timothy Cloughesy; Linda M Liau; Paul S Mischel; Stanley F Nelson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

2.  Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer.

Authors:  H Telenius; N P Carter; C E Bebb; M Nordenskjöld; B A Ponder; A Tunnacliffe
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

3.  Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.

Authors:  Michelle R Stettner; Wenquan Wang; L Burton Nabors; Suman Bharara; Daniel C Flynn; J Robert Grammer; G Yancey Gillespie; Candece L Gladson
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Brain slice invasion model reveals genes differentially regulated in glioma invasion.

Authors:  Nikola Holtkamp; Anastasia Afanasieva; Anja Elstner; Frank K H van Landeghem; Matthias Könneker; Susanne A Kuhn; Helmut Kettenmann; Andreas von Deimling
Journal:  Biochem Biophys Res Commun       Date:  2005-11-04       Impact factor: 3.575

5.  Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction.

Authors:  Vincent Sauzeau; María A Sevilla; Juan V Rivas-Elena; Enrique de Alava; María J Montero; José M López-Novoa; Xosé R Bustelo
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

6.  Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.

Authors:  X R Bustelo; K L Suen; K Leftheris; C A Meyers; M Barbacid
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 8.  Recent advances in the molecular genetics of primary gliomas.

Authors:  Gaspar J Kitange; Kristen L Templeton; Robert B Jenkins
Journal:  Curr Opin Oncol       Date:  2003-05       Impact factor: 3.645

9.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 10.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

View more
  5 in total

1.  Robust meta-analysis shows that glioma transcriptional subtyping complements traditional approaches.

Authors:  Sanghoon Lee; Stephen R Piccolo; Kristina Allen-Brady
Journal:  Cell Oncol (Dordr)       Date:  2014-08-21       Impact factor: 6.730

2.  TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.

Authors:  P-H Huang; P-J Lu; L-Y Ding; P-C Chu; W-Y Hsu; C-S Chen; C-C Tsao; B-H Chen; C-T Lee; Y-S Shan; C-S Chen
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

Review 3.  Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.

Authors:  Shulamit Katzav
Journal:  Oncotarget       Date:  2015-10-06

Review 4.  The Role of Non-coding RNAs in Alzheimer's Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers.

Authors:  Yuan Zhang; Yanfang Zhao; Xiang Ao; Wanpeng Yu; Lei Zhang; Yu Wang; Wenguang Chang
Journal:  Front Aging Neurosci       Date:  2021-07-02       Impact factor: 5.750

Review 5.  Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Authors:  Shannon Patricia Fortin Ensign; Ian T Mathews; Marc H Symons; Michael E Berens; Nhan L Tran
Journal:  Front Oncol       Date:  2013-10-04       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.